NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
64 hedge funds and large institutions have $18.4M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
64% less capital invested
Capital invested by funds: $50.6M → $18.4M (-$32.1M)
Holders
64
Holding in Top 10
–
Calls
$2.55M
Puts
$871K
Top Buyers
| 1 | +$4.51M | |
| 2 | +$941K | |
| 3 | +$727K | |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$521K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$476K |
Top Sellers
| 1 | -$8.62M | |
| 2 | -$3.98M | |
| 3 | -$3.82M | |
| 4 |
Millennium Management
New York
|
-$1.84M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.08M |